Since hypoglycemia is known to correlate with vascular endothelial dysfunction in the clinical setting in diabetic patients under treatment, we recommend that diabetic patients who require frequent insulin injections or sulfonylureas (SU) should be provided with a treatment/management protocol that guards against the development of hypoglycemia in order to prevent cardiovascular events. This evidence concerns the gene INS and Hypoglycemia.